These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 36915062)
21. Rates of appropriate laxative prophylaxis for opioid-induced constipation in veterans with lung cancer: a retrospective cohort study. Brown TJ; Keshvani N; Gupta A; Yang H; Agrawal D; Le TC; Gerber DE; Alvarez CA Support Care Cancer; 2020 Nov; 28(11):5315-5321. PubMed ID: 32124025 [TBL] [Abstract][Full Text] [Related]
22. Osmotic and stimulant laxatives for the management of childhood constipation. Gordon M; Naidoo K; Akobeng AK; Thomas AG Cochrane Database Syst Rev; 2012 Jul; (7):CD009118. PubMed ID: 22786523 [TBL] [Abstract][Full Text] [Related]
23. Randomised clinical trial: the long-term safety and tolerability of naloxegol in patients with pain and opioid-induced constipation. Webster L; Chey WD; Tack J; Lappalainen J; Diva U; Sostek M Aliment Pharmacol Ther; 2014 Oct; 40(7):771-9. PubMed ID: 25112584 [TBL] [Abstract][Full Text] [Related]
24. Non-analgesic effects of opioids: management of opioid-induced constipation by peripheral opioid receptor antagonists: prevention or withdrawal? Holzer P Curr Pharm Des; 2012; 18(37):6010-20. PubMed ID: 22747544 [TBL] [Abstract][Full Text] [Related]
25. Comparison of the effectiveness of polyethylene glycol 4000 without electrolytes and magnesium hydroxide in the treatment of chronic functional constipation in children. Gomes PB; Duarte MA; Melo Mdo C J Pediatr (Rio J); 2011; 87(1):24-8. PubMed ID: 21116598 [TBL] [Abstract][Full Text] [Related]
26. A Randomized, Multicenter, Prospective, Crossover, Open-Label Study of Factors Associated With Patient Preferences for Naloxegol or PEG 3350 for Opioid-Induced Constipation. Brenner DM; Hu Y; Datto C; Creanga D; Camilleri M Am J Gastroenterol; 2019 Jun; 114(6):954-963. PubMed ID: 31058652 [TBL] [Abstract][Full Text] [Related]
27. [Opioid-Induced Constipation in Patients with Cancer Pain]. Aruga E Gan To Kagaku Ryoho; 2021 Nov; 48(11):1311-1315. PubMed ID: 34795117 [TBL] [Abstract][Full Text] [Related]
28. Laxative management in ambulatory cancer patients on opioid therapy: a prospective, open-label investigation of polyethylene glycol, sodium picosulphate and lactulose. Wirz S; Nadstawek J; Elsen C; Junker U; Wartenberg HC Eur J Cancer Care (Engl); 2012 Jan; 21(1):131-40. PubMed ID: 21880080 [TBL] [Abstract][Full Text] [Related]
29. Management of Opioid-Induced Constipation in Hospice Patients. Sera L; McPherson ML Am J Hosp Palliat Care; 2018 Feb; 35(2):330-335. PubMed ID: 28423917 [TBL] [Abstract][Full Text] [Related]
30. Management of Opioid-induced Constipation in Older Adults. Horrigan J; Bhumi S; Miller D; Jafri M; Tadros M J Clin Gastroenterol; 2023 Jan; 57(1):39-47. PubMed ID: 36504229 [TBL] [Abstract][Full Text] [Related]
31. The Burden of Opioid-Induced Constipation: Discordance Between Patient and Health Care Provider Reports. LoCasale RJ; Datto C; Wilson H; Yeomans K; Coyne KS J Manag Care Spec Pharm; 2016 Mar; 22(3):236-45. PubMed ID: 27003553 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of a Pharmacist-Driven Protocol for the Treatment of Opioid-Induced Constipation. Tryson AR; Hennessey EK; Crannage AJ J Pharm Pract; 2022 Apr; 35(2):218-222. PubMed ID: 35484871 [TBL] [Abstract][Full Text] [Related]
33. [Survey of Prophylactic Administration of Naldemedine for Opioid-induced Constipation]. Ozawa Y; Haruki Y; Ohata M; Isono H; Takahashi M; Tate A; Ukita S; Hayashi S Yakugaku Zasshi; 2023; 143(2):183-189. PubMed ID: 36724931 [TBL] [Abstract][Full Text] [Related]
34. Opioid-induced constipation in patients with cancer pain in Japan (OIC-J study): a post hoc subgroup analysis of patients with gastrointestinal cancer. Harada T; Imai H; Fumita S; Noriyuki T; Gamoh M; Okamoto M; Akashi Y; Kizawa Y; Tokoro A Int J Clin Oncol; 2021 Jan; 26(1):104-110. PubMed ID: 33068220 [TBL] [Abstract][Full Text] [Related]
35. Delphi consensus on strategies in the management of opioid-induced constipation in cancer patients. Sarrió RG; Calsina-Berna A; García AG; Esparza-Miñana JM; Ferrer EF; ; Porta-Sales J BMC Palliat Care; 2021 Jan; 20(1):1. PubMed ID: 33388041 [TBL] [Abstract][Full Text] [Related]
37. An Evaluation of Docusate Monotherapy and the Prevention of Opioid-Induced Constipation after Surgery. Yang A; Lam T; Jierjian E; Walden SG; Coulson EE J Pain Palliat Care Pharmacother; 2022 Mar; 36(1):18-23. PubMed ID: 35481823 [TBL] [Abstract][Full Text] [Related]
38. Characterization and Associated Costs of Constipation Relating to Exposure to Strong Opioids in England: An Observational Study. Morgan CL; Jenkins-Jones S; Knaggs R; Currie C; Conway P; Poole CD; Berni E Clin Ther; 2021 Jun; 43(6):968-989. PubMed ID: 33931241 [TBL] [Abstract][Full Text] [Related]
39. Patients' Self-Assessment of the Symptoms and Impact of Opioid-Induced Constipation: Results From a Prospective Observational Cohort Study of Japanese Patients With Cancer. Fumita S; Imai H; Harada T; Noriyuki T; Gamoh M; Akashi Y; Sato H; Kizawa Y; Tokoro A J Pain Symptom Manage; 2020 May; 59(5):1043-1051.e2. PubMed ID: 31805362 [TBL] [Abstract][Full Text] [Related]